D-Index & Metrics Best Publications
Research.com 2023 Best Scientist Award Badge

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 166 Citations 107,454 973 World Ranking 338 National Ranking 217
Best Scientists D-index 166 Citations 107,455 980 World Ranking 661 National Ranking 426

Research.com Recognitions

Awards & Achievements

2023 - Research.com Best Scientist Award

2022 - Research.com Best Scientist Award

Jubilee Prize, Swedish Medical Society

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Disease

Hans-Olov Adami focuses on Internal medicine, Cancer, Risk factor, Epidemiology and Gynecology. Hans-Olov Adami interconnects Gastroenterology, Surgery and Oncology in the investigation of issues within Internal medicine. His work carried out in the field of Cancer brings together such families of science as Immunology and Pathology.

The study incorporates disciplines such as Endocrinology, Absolute risk reduction, Case-control study and Environmental health in addition to Risk factor. Hans-Olov Adami works mostly in the field of Epidemiology, limiting it down to concerns involving Incidence and, occasionally, Demography, Mass screening, Mortality rate and Colorectal cancer. The Gynecology study combines topics in areas such as Body mass index, Cervical cancer, Obstetrics, Breast cancer and Cohort.

His most cited work include:

  • Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer (2099 citations)
  • Radical prostatectomy versus watchful waiting in early prostate cancer. (1702 citations)
  • Radical prostatectomy versus watchful waiting in early prostate cancer. (1702 citations)

What are the main themes of his work throughout his whole career to date?

Hans-Olov Adami mostly deals with Internal medicine, Cancer, Epidemiology, Breast cancer and Oncology. His work deals with themes such as Endocrinology and Surgery, which intersect with Internal medicine. His Cancer research incorporates themes from Gastroenterology and Pathology.

His Epidemiology study incorporates themes from Incidence, Environmental health, Demography, Confidence interval and Public health. His Breast cancer study which covers Gynecology that intersects with Obstetrics, Cervical cancer, Endometrial cancer, Confounding and Menopause. His study in Risk factor is interdisciplinary in nature, drawing from both Odds ratio, Absolute risk reduction, Case-control study, Immunology and Disease.

He most often published in these fields:

  • Internal medicine (72.13%)
  • Cancer (45.00%)
  • Epidemiology (37.35%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (72.13%)
  • Oncology (33.31%)
  • Cancer (45.00%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Oncology, Cancer, Cohort and Epidemiology. His study looks at the relationship between Oncology and fields such as Disease, as well as how they intersect with chemical problems. The concepts of his Cancer study are interwoven with issues in Twin study, Heritability, Incidence, Gastroenterology and Lower risk.

His work in Incidence addresses issues such as Relative risk, which are connected to fields such as Gynecology. The various areas that Hans-Olov Adami examines in his Cohort study include Demography, Retrospective cohort study and Ovarian cancer. His work in Epidemiology covers topics such as Public health which are related to areas like Family medicine.

Between 2015 and 2021, his most popular works were:

  • Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults (534 citations)
  • Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults (534 citations)
  • Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. (312 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

Internal medicine, Oncology, Cancer, Prospective cohort study and Body mass index are his primary areas of study. His Surgery research extends to the thematically linked field of Internal medicine. His Oncology research is multidisciplinary, incorporating elements of Survival rate and Breast cancer.

His Breast cancer study combines topics in areas such as Young adult, Family history, Obstetrics and Risk factor. His research in Cancer intersects with topics in Twin study, Lower risk, Lung cancer and Gastroenterology. Hans-Olov Adami has included themes like Epidemiology and Retrospective cohort study in his Prospective cohort study study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

E. E. Calle;C. W. Heath;R. J. Coates;J. M. Liff.
The Lancet (1997)

3561 Citations

Ulcerative colitis and colorectal cancer. A population-based study.

Anders Ekbom;Charles Helmick;Matthew Zack;Hans-Olov Adami.
The New England Journal of Medicine (1990)

2247 Citations

Radical prostatectomy versus watchful waiting in early prostate cancer.

Anna Bill-Axelson;Anna Bill-Axelson;Lars Holmberg;Mirja Ruutu;Hans Garmo.
The New England Journal of Medicine (2005)

1749 Citations

Breast cancer and hormonal contraceptives : collaborative reanalysis of individual data on 53.297 women with breast cancer and 100.239 women without breast cancer from 54 epidemiological studies

E. E. Calle;C. W. Heath;H. L. Miracle-McMahill;R. J. Coates.
The Lancet (1996)

1723 Citations

Epidemiology and etiology of Parkinson’s disease: a review of the evidence

Karin Wirdefeldt;Hans-Olov Adami;Hans-Olov Adami;Philip Cole;Dimitrios Trichopoulos.
European Journal of Epidemiology (2011)

1420 Citations

The enigmatic epidemiology of nasopharyngeal carcinoma.

Ellen T. Chang;Hans-Olov Adami.
Cancer Epidemiology, Biomarkers & Prevention (2006)

1395 Citations

Leisure Time Physical Activity and Mortality: A Detailed Pooled Analysis of the Dose-Response Relationship

Hannah Arem;Steven C. Moore;Alpa Patel;Patricia Hartge.
JAMA Internal Medicine (2015)

1279 Citations

Pooled Analysis of Prospective Cohort Studies on Height, Weight, and Breast Cancer Risk

Piet A. Van Den Brandt;Donna Spiegelman;Shiaw Shyuan Yaun;Hans Olov Adami.
American Journal of Epidemiology (2000)

1189 Citations

Overweight as an avoidable cause of cancer in Europe

Anna Bergström;Paola Pisani;Vanessa Tenet;Alicja Wolk.
International Journal of Cancer (2001)

1097 Citations

A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer

Lars Holmberg;Anna Bill-Axelson;Fred Helgesen;Jaakko O. Salo.
The New England Journal of Medicine (2002)

1092 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hans-Olov Adami

Walter C. Willett

Walter C. Willett

Harvard University

Publications: 321

Carlo La Vecchia

Carlo La Vecchia

University of Milan

Publications: 315

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 300

Susan E. Hankinson

Susan E. Hankinson

University of Massachusetts Amherst

Publications: 221

Kari Hemminki

Kari Hemminki

Charles University

Publications: 218

Elio Riboli

Elio Riboli

Imperial College London

Publications: 215

Elisabete Weiderpass

Elisabete Weiderpass

International Agency For Research On Cancer

Publications: 214

Silvia Franceschi

Silvia Franceschi

Centro di Riferimento Oncologico

Publications: 214

Graham A. Colditz

Graham A. Colditz

Washington University in St. Louis

Publications: 206

Paolo Boffetta

Paolo Boffetta

Stony Brook Medicine

Publications: 204

Dimitrios Trichopoulos

Dimitrios Trichopoulos

Harvard University

Publications: 200

Alicja Wolk

Alicja Wolk

Karolinska Institute

Publications: 197

Meir J. Stampfer

Meir J. Stampfer

Harvard University

Publications: 193

Anne Tjønneland

Anne Tjønneland

University of Copenhagen

Publications: 192

Kim Overvad

Kim Overvad

Aarhus University

Publications: 180

Rudolf Kaaks

Rudolf Kaaks

German Cancer Research Center

Publications: 178

Trending Scientists

Wen-Hsiang Tsai

Wen-Hsiang Tsai

National Yang Ming Chiao Tung University

Nikos Vlassis

Nikos Vlassis

Netflix (United States)

Jonathan Cagan

Jonathan Cagan

Carnegie Mellon University

Kengo Shimanoe

Kengo Shimanoe

Kyushu University

Tomihiro Hashizume

Tomihiro Hashizume

Hitachi (Japan)

Simon J. Boulton

Simon J. Boulton

The Francis Crick Institute

John J. Wasmuth

John J. Wasmuth

University of California, Irvine

Randall J. Olsen

Randall J. Olsen

Houston Methodist

Fred Sinowatz

Fred Sinowatz

Ludwig-Maximilians-Universität München

Beverly E. Griffin

Beverly E. Griffin

Imperial College London

Reinhard Ebner

Reinhard Ebner

Human Genome Sciences (United States)

Stephen Higgs

Stephen Higgs

Kansas State University

Richard Coleman

Richard Coleman

University of Tasmania

Christopher Daly

Christopher Daly

Oregon State University

Philip L. Felgner

Philip L. Felgner

University of California, Irvine

Graham Martin

Graham Martin

University of Queensland

Something went wrong. Please try again later.